Short interest in Bright Minds Biosciences Inc (NASDAQ:DRUG) decreased during the last reporting period, falling from 264.76K to 221.37K. This put 4.26% of the company's publicly available shares short.

Short interest for Bright Minds Biosciences gives investors a sense of the degree to which investors are betting on the decline of Bright Minds Biosciences's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 212.19K shares traded per day, it would take 1.04 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.